Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1990 Jan;79(1):28-34.
doi: 10.1111/j.1365-2249.1990.tb05122.x.

Natural killer cell activity, interferon-gamma and antibodies to herpes viruses in patients with Behçet's disease

Affiliations

Natural killer cell activity, interferon-gamma and antibodies to herpes viruses in patients with Behçet's disease

K Hamzaoui et al. Clin Exp Immunol. 1990 Jan.

Abstract

Interferon-gamma (IFN-gamma) titres in 20 patients with active Behçet's disease were examined and compared with those of 20 normal donors. Sera from Behçet's disease patients revealed an IFN-gamma increase but no correlation between IFN level and natural killer (NK) activity. The analysis of lymphocyte subsets by monoclonal antibodies registered an increase of CD8+ T subpopulation and cells co-expressing CD8(+)-Leu7a+ markers. Moreover, a high number of cells expressing CD25+ and HLA-DR+ phenotype has been noted in patients with active Behçet's disease. Serological analysis showed a high level of IgG antibodies to HSV-1. The increase of IFN-gamma titre, the high number of activated T cells and the increasing level of IgG antibodies to HSV-1 are important manifestations during the active stage of Behçet's disease. These findings are discussed in relation to the immunopathogenesis of Behçet's disease.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Clin Exp Immunol. 1988 Jan;71(1):126-31 - PubMed
    1. Clin Exp Immunol. 1988 Jul;73(1):6-10 - PubMed
    1. Clin Exp Immunol. 1984 Sep;57(3):541-7 - PubMed
    1. Ann Rheum Dis. 1986 Mar;45(3):220-4 - PubMed
    1. J Clin Lab Immunol. 1986 Apr;19(4):181-6 - PubMed